Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence.
about
Diabetes and cancer: two diseases with obesity as a common risk factorEpithelial cancers in the post-genomic era: should we reconsider our lifestyle?Gene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING StudiesShared common variants in prostate cancer and blood lipids.Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population.The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health StudyCancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individualsAssociation of Family History of Type 2 Diabetes with Prostate Cancer: A National Cohort Study.Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.Tumor features and survival after radical prostatectomy among antidiabetic drug users.The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro.Effect of high mobility group box 1 on the human retinal pigment epithelial cell in high-glucose condition.Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.Cancer risk in patients with type 2 diabetes mellitus and their relatives.Diabetes mellitus and risk of prostate cancer in the EuropeanProspectiveInvestigation into Cancer and Nutrition
P2860
Q26822753-74962827-4D97-4EC1-9610-19FA310BCC4DQ28391921-BC97554F-DA76-46CB-98B7-74D9435D7116Q28397345-673DA45A-00AC-4449-9D5D-875827A411C6Q34001263-5492633E-1676-464E-B1DD-942D5A74E8C5Q34149590-B6B70579-AD85-40B2-A796-E9F8FC4198B8Q36663029-BA393EB5-9B3A-4262-8932-7A80FC00319FQ36783114-28DA0786-1AED-4F6C-8FD6-75A2D98985C4Q37212818-CACB1A1E-6DCF-48BB-9A33-50C8CE538DDFQ37561605-F2122043-5DC3-4AD8-B735-E5C6765CE92CQ39199949-6C9E17CF-FEB1-4F3B-AD57-9F0C2F73DE9EQ39510855-72FB5E94-46FE-44F6-A89C-E1EAB9DF2701Q39838333-436388CB-AF4A-406D-BC66-5D11DD6D67B3Q40104873-709EF9C7-D13E-4657-A3B0-C3BF56F8AEE4Q40382361-3FFE5DF0-38CE-4BB1-809D-CDF95310B3B4Q51244733-2F2D4721-58C4-4FAF-8974-29099089785AQ53639960-A7EF9C1F-552E-4B3A-A98E-EBB8F6120383Q56987983-5AF8A811-8B2C-48AD-A98B-0C9FA22049E9
P2860
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Why are diabetics at reduced r ...... of the epidemiologic evidence.
@en
type
label
Why are diabetics at reduced r ...... of the epidemiologic evidence.
@en
prefLabel
Why are diabetics at reduced r ...... of the epidemiologic evidence.
@en
P1433
P1476
Why are diabetics at reduced r ...... of the epidemiologic evidence
@en
P2093
Brandon L Pierce
P304
P356
10.1016/J.UROLONC.2012.07.008
P577
2012-09-01T00:00:00Z